233276-38-5 Usage
Description
2H-Pyran-4-carboxylic acid, tetrahydro-4-methyl-(9CI), also known as tetrahydro-4-methyl-2H-pyran-4-carboxylic acid, is a chemical compound with the molecular formula C8H12O3. It is a derivative of pyran, a six-membered heterocyclic compound containing one oxygen atom. 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-(9CI) is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various compounds. Additionally, it is known for its potential biological activities and is being studied for its potential pharmacological and medicinal applications.
Uses
Used in Organic Synthesis:
2H-Pyran-4-carboxylic acid, tetrahydro-4-methyl-(9CI) is used as a building block in organic synthesis for the creation of various compounds. Its unique structure and functional groups make it a versatile component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2H-Pyran-4-carboxylic acid, tetrahydro-4-methyl-(9CI) is used as a key intermediate in the development of new drugs. Its potential biological activities and pharmacological properties are being explored for the treatment of various diseases and conditions.
Used in Medicinal Applications:
2H-Pyran-4-carboxylic acid, tetrahydro-4-methyl-(9CI) is being studied for its potential medicinal applications due to its biological activities. Researchers are investigating its therapeutic potential in the development of new medications for various health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 233276-38-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,3,2,7 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 233276-38:
(8*2)+(7*3)+(6*3)+(5*2)+(4*7)+(3*6)+(2*3)+(1*8)=125
125 % 10 = 5
So 233276-38-5 is a valid CAS Registry Number.
233276-38-5Relevant articles and documents
NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST
-
Paragraph 0581, (2017/04/18)
The present invention relates to a novel pyrrolidine compound having melanocortin receptor agonist activity or a pharmaceutically acceptable salt thereof, and to pharmaceutical applications thereof. The present invention relates to a pyrrolidine derivative represented by formula [I], wherein ring A represents an optionally substituted aryl group or the like; R1 represents an optionally substituted alkyl group or the like; R2 represents a halogen atom or the like; and R3 is an alkyl group substituted with an optionally substituted aryl group or the like, and R4 is a hydrogen atom or the like; or R3 and R4 are terminally attached to each other, and together with the nitrogen atom to which they are attached, form an optionally substituted nitrogen-containing aliphatic heterocyclic ring that may partially contain a double bond; or to a pharmaceutically acceptable salt thereof.
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
-
Paragraph 0400, (2014/09/30)
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
